PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Lilly to collaborate with Precision BioSciences on genome editing research

Eli Lilly has entered a research collaboration and exclusive license agreement with Precision BioSciences to use genome editing to develop therapies for genetic diso...
Continue Reading →
News

Sanofi’s meningococcal vaccine wins EU approval

French pharma company Sanofi has won approval from the European Commission (EC) for its meningococcal (MenACWY) vaccine MenQuadfi. The EC has given MenQuadfi the g...
Continue Reading →
News

FDA approves new dosing option for AZ’s Imfinzi

The US Food and Drug Administration (FDA) has approved AstraZeneca’s (AZ) checkpoint inhibitor Imfinzi for an additional dosing option. Imfinzi (durvalumab) has be...
Continue Reading →
News

Amgen hands back heart failure programme rights to Cytokinetics

Amgen has handed back the rights to two investigational heart failure programmes to Cytokinetics after one of the drugs failed to demonstrate impressive results in a...
Continue Reading →
News

NICE backs Braftovi for BRAF-positive colorectal cancer

The National Institute for Health and Care Excellence (NICE) has back Pierre Fabre’s Braftovi plus cetuximab for the treatment of BRAF-positive metastatic colorectal...
Continue Reading →
News

CPhI & P-MEC China 2020 adapts to customer needs with hybrid pharma event

Virtual Expo Connect to empower access for international pharma to the world’s largest pharma ingredients market Amsterdam, 17 November 2020: CPhI & P-MEC Chin...
Continue Reading →
News

NHS launches 40 ‘long COVID’ clinics

The NHS is rolling out a network of more than 40 long COVID specialist clinics in the next few weeks to help thousands of patients who are suffering debilitating eff...
Continue Reading →
News

MHRA starts rolling review of AZ’s coronavirus vaccine

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has started an accelerated or rolling review of AstraZeneca’s coronavirus vaccine candidate, the ...
Continue Reading →
News

UK strikes deal for five million doses of Moderna’s COVID-19 vaccine

The UK government has secured access to five million doses of Moderna’s COVID-19 vaccine after interim data, released yesterday, suggested that the shot is 94.5% eff...
Continue Reading →
News

Lead Pharma and Roche enter €260m collaboration agreement

Dutch company Lead Pharma has entered a collaboration and licence agreement with Swiss pharma giant Roche to develop oral small molecules for a ‘broad range’ of immu...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026